Protocol No. 28431754DNE3001: "A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabetic Nephropathy"
Clinical Trial Grant
Administered By
Medicine, Nephrology
Awarded By
Janssen Research & Development, LLC
Start Date
November 1, 2014
End Date
March 1, 2019
Administered By
Medicine, Nephrology
Awarded By
Janssen Research & Development, LLC
Start Date
November 1, 2014
End Date
March 1, 2019